IGI Laboratories weakness a buying opportunity, says Craig-Hallum Craig-Hallum recommends buying IGI Laboratories and is confident in the growth opportunities and expected ANDA approvals. Shares are Buy rated.
IGI Laboratories director Damian Finio resigns IGI Laboratories has accepted Damian Finio's resignation from its Board of Directors effective August 11. Mr. Finio has accepted a senior level finance position at a pharmaceutical company, and will be unable to continue in his role as Director. The company has begun a search to replace Mr. Finio on its Board.